Geographical distribution of HIV-1 group O viruses in Africa

AIDS

Volumn 11, Issue 4, 1997, Pages 493-498

  Peeters, Martine ^a   Gueye, Aissatou ^b   Mboup, Souleymane ^b   Bibollet Ruche, Frederic ^a   Ekaza, Euloge ^a   Mulanga, Claire ^a   Ouedrago, Rasmata ^c   Gandji, Regine ^d   Mpele, Pierre ^e   Dibanga, Germaine ^f   Koumare, Brahima ^g   Saidou, Mamadou ^h   Esu Williams, Eka ⁱ   Lombart, Jean Piere ^j   Badombena, Wanta ^k   Luo, Nkandu ^l   Vanden Haesevelde, Marleen ^m   Delaporte, Eric ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b Centre Hospitalier Universitaire Aristide Le Dantec de Dakar   (Senegal)

^c Dept of Int Med and Cardiology   (Burkina Faso)

^d Hopital Laquintinie   (Cameroon)

^e National AIDS Control Programmes   (Congo)

^f Inst Natl de Santé Publique ^*

^g Inst Nat de Rech Sante Publique   (Mali)

^h Centre Hospitalier Universitaire   (Mali)

ⁱ UNIVERSITY OF CALABAR   (Nigeria)

^j Centre de Transfusion Sanguine   (Nigeria)

^k Serv S Forces Armees Togolaises   (Chad)

^l UNIVERSITY OF ZAMBIA   (Zambia)

^m INNOGENETICS   (Belgium)

more..

Author keywords

Africa; HIV 1 group O; Serotyping

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; CAMEROON; CHAD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GABON; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; NIGER; NIGERIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENEGAL; TOGO;

EID: 8044230048     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199704000-00013     Document Type: Article

References (27)

1. Charneau P, Borman A, Quillent C, et al.: Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology 1994, 205:247-255.
2. Louwagie J, McCutchan F, Peeters M, et al.: Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993, 7:769-780.
3. Janssens W, Heyndrickx L, Fransen K, et al.: Genetic and phylogenetic analysis of env subtypes G and H in Africa. AIDS Res Hum Retrovirus 1994, 10:877-879.
4. Kostrikis L, Bagdades E, Cao Y, Zhang L, Dimitriou D, Ho D: Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated I. J Virol 1995, 69:6122-6130.
5. Meyers G, Korber B, Hahn B, et al. (Eds): Human Retroviruses and AIDS 1995: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos: Los Alamos National Laboratory; 1995.
6. Vanden Haesevelde M, Decourt JL, De Leys RJ, et al.: Genomic cloning and complete sequence analysis of a highly divergent African human virus isolate. J Virol 1994, 68:1586-1596.
7. Gurtler L, Hauser PH, Eberle J, et al.: A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994, 68:1581-1585.
8. Loussert-Ajaka I, Chaix ML, Korber B, et al.: Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1195, 69:5640-5649.
9. Hampl H, Sawitzky D, Stöfller-Meilicke M, et al.: First case of HIV-1 subtype O infection in Germany [letter]. Infection 1995, 6:369-370.
10. Soriano V, Guttierez M, Garcia-Lerma G, et al.: First case of group O infection in Spain [letter]. Vox Sang 1996, 71:66.
11. Centers tor Disease Control and Prevention: Identification of HIV-1 group O infection, Los Angeles Country, California, 1996. MMWR 1996, 45:561-564.
12. ANT-70 virus in Cameroon and Gabon. AIDS 1993, 7:1536-1538.
13. Mulanga Kabeya C, Esu-Williams E, Enu E, Peeters M, Delaporte E: Evidence for HIV-1 group O infection in Nigeria [letter]. Lancet 1995, 346:308.
14. Hunt JC, Golden AM, Vallan A, et al.: Molecular and serologic characterization of four HIV-1 group O sera from Equatorial Guinea. AIDS Res Hum Retrovirus 1995, 11 (suppl 1):S1-44.
15. Songok EM, Libondo DK, Rotich MC, Oogo SA, Tukei PM. Surveillance for HIV-1 subtypes O and M in Kenya [letter]. Lancet 1996, 347:1700.
16. Heyndrickx L, Alary M, Janssens W, Davo N, van der Groen G. HIV-1 group O and group M dual infection in Benin [letter]. Lancet 1996, 347:902-905.
17. Loussert-Ajaka I, Ly T-D, Chaix ML, et al.: HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994, 343:1393-1394.
18. Schable C, Zekeng L, Pau C-P, et al.: Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994, 344:1333-1334.
19. Simon F, Ly TD, Baillou-Beaufils A, et al.: Sensitivity of screening kits for anti-HIV-1 subtype O antibodies. AIDS 1994, 8:1628-1629.
20. Zekeng L, Gurtler L, Afaneze A, et al.: Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results. AIDS 1994, 8:1626-1628.
21. Gurtler L: Difficulties and strategies of HIV diagnosis. Lancet 1996, 348:176-179.
22. Janssens W, Nkengasong JN, Heyndrickx L, et al.: Further evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon. AIDS 1994, 8:1012-1013.
23. Peeters M, Gaye A, Mboup S, et al.: Presence of HIV-1 group O infection in West Africa. AIDS 1996, 10:343-344.
24. ANT-70 isolate in human sera from different geographic regions. AIDS 1994, 8:1657-1661.
25. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
26. Fransen K, Zhong P, De Beenhouwer H, et al.: Design and evaluation of new, highly sensitive and specific primers for polymerase chain reaction detection of HIV-1 infected primary lymphocytes. Mol Cell Probes 1994, 8: 317-322.
27. Janssens VV, Fransen K, Loussert-Ajaka I, et al.: Diagnosis of HIV-1 group O infection by polymerase chain reaction. Lancet 1995, 346:451-452.